Special Issue "Marine Organisms with Neuroprotective Activity: Molecular Targets and Action Mechanisms"
A special issue of Marine Drugs (ISSN 1660-3397).
Deadline for manuscript submissions: closed (30 October 2019).
Interests: Alzheimer's disease; neurodegenerative diseases; translational behavioral neuroscience and pharmacology; aging; behavioral neuroendocrinology; neuropharmacology
Interests: pharmacology; analytical biochemistry; signal transduction; compound isolation
Special Issues and Collections in MDPI journals
Special Issue in Toxins: Selected Papers from the 5th Iberoamerican Cyanotoxins Meeting
Special Issue in Toxins: Bio-Monitoring of Marine and Fresh Water Toxins in Europe and North America
Topical Collection in Toxins: Toxicological Challenges of Aquatic Toxins
Marine compounds have shown an extreme diversity in both chemical structure and modes of action. There is no doubt that the future of neuroprotection will include several natural or derived marine compounds, as the literature is now suggesting. The privileged structures provided by marine organisms bring about the question of why they are producing this variety of compounds so active in mammals, but their use is potentially very promising, not only in terms of action, but also because their molecular size and kinetics favor their development as drug leads.
This Special Issue of marine organisms with neuroprotective activity seeks to highlight the potential of marine drugs for neuroprotection, with a special emphasis on the diversity of molecular targets and mechanistic effects. Original (in vitro, animal, and clinical), review, and conceptual articles on known and novel bioactive marine products with potential neuroprotective activity and its translational value are encouraged.
Prof. Dr. Lydia Giménez-Llort
Prof. Dr. Luis M. Botana
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Marine toxins
- Molecular targets
- Mechanisms of action
- Translational research